Effect of GLP1 Receptor Agonist on Brain Insulin Responsiveness

Clinical trial NCT06487832 · RECRUITING

Trial details

NCT number: NCT06487832
Sponsor: University Hospital Tuebingen
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Normal Weight Overweight and Obesity Insulin Sensitivity Insulin Resistance

Start date: 2024-07-01
Primary completion: 2027-07-31
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.